Kellen Cristhina Fae

Title: Kellen Cristhina Fae: Innovator in Immunology

Introduction

Kellen Cristhina Fae is a notable inventor based in Oegstgeest, Netherlands. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 4 patents, Fae has focused on developing novel approaches to stimulate immune responses.

Latest Patents

Fae's latest patents include groundbreaking work on FimH mutants and multivalent vaccine compositions. The first patent describes polypeptides comprising a FimH lectin domain with amino acid mutations that alter its affinity for mannose. This innovation aims to enhance pharmaceutical compositions that stimulate immune responses in individuals. The second patent outlines methods and compositions for inducing immune responses against extra-intestinal pathogenic E. coli (ExPEC), utilizing conjugates of polysaccharide antigen O75 bound to carrier proteins to prevent invasive ExPEC diseases.

Career Highlights

Throughout his career, Kellen Cristhina Fae has worked with prominent companies in the pharmaceutical industry. He has been associated with Janssen Pharmaceuticals, Inc. and GlaxoSmithKline Biologicals SA, where he has contributed to various research and development projects. His work has been instrumental in advancing vaccine technologies and therapeutic strategies.

Collaborations

Fae has collaborated with several professionals in his field, including Jeroen Geurtsen and Eveline Marleen Weerdenburg. These collaborations have fostered innovation and have been crucial in the development of his patented technologies.

Conclusion

Kellen Cristhina Fae is a distinguished inventor whose work in immunology has led to significant advancements in vaccine development and immune response stimulation. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.